A prospective study for active surveillance the correlation between thyroid papillary microcarcinoma and multiple factors

Correlation analysis among Braf gene, hormone level and active surveillance in thyroid micropapillary carcinoma

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900022094

Enrollment

Unknown

Registered

2019-03-24

Start date

2019-04-01

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid carcinoma

Interventions

AS group:active surveillence

surgery group:surgery

MWA group:microwave ablation

Eligibility

Sex/Gender

All

Age

1 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) thyroid papillary carcinoma (Bethesda VI) by pathology; (2) the diameter of nodules is less than 1cm.

Exclusion criteria

Exclusion criteria: (1) With a family history of thyroid cancer; (2) Clinically confirmed cervical lymph node metastasis or distant metastasis; (3) The tumor invade the thyroid capsule or the extrathyroid tissues,eg.the adjacent trachea or recurrent laryngeal nerve.

Design outcomes

Primary

Measure	Time frame
brafv600e gene;Hormonal state;hardness measurement by SWE;mean diameter;	—

Secondary

Measure	Time frame
Quality of life assessment;Prognostic evaluation;	—

Countries

China

Contacts

Public ContactQian Linxue

qianlinxue2002@163.com+86 13311100999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026